{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:07:57Z","timestamp":1792390077668,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2017\/25\/B\/ST5\/00291"],"award-info":[{"award-number":["UMO-2017\/25\/B\/ST5\/00291"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejmech.2020.112624","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:20:28Z","timestamp":1593724828000},"page":"112624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-0462","authenticated-orcid":false,"given":"Natalia","family":"Skrzypczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-9990","authenticated-orcid":false,"given":"Krystian","family":"Pyta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5106-8510","authenticated-orcid":false,"given":"Piotr","family":"Ruszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-7193","authenticated-orcid":false,"given":"Maria","family":"Gdaniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Przybylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112624_bib1","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1080\/14786419.2016.1263854","article-title":"Production of 17-O-demethyl-geldanamycin, a cytotoxic ansamycin polyketide, by Streptomyces hygroscopicus DEM20745","volume":"31","author":"Baksh","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2020.112624_bib2","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1039\/C9OB00892F","article-title":"New geldanamycin derivatives with anti Hsp properties by mutasynthesis","volume":"17","author":"Hermane","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.biopha.2018.03.102","article-title":"Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: overview and current state of the art","volume":"102","author":"Mellatyar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2020.112624_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/cbdd.13486","article-title":"Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment","volume":"93","author":"Talaei","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112624_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/jm9004708","article-title":"Heat shock protein 90: inhibitors in clinical trials","volume":"53","author":"Biamonte","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib6","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/j.bmc.2004.07.053","article-title":"Synthesis and biological activities of novel 17-aminogeldanamycin derivatives","volume":"12","author":"Tian","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1039\/c3np70012g","article-title":"Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy","volume":"30","author":"Franke","year":"2013","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2020.112624_bib8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/acs.jmedchem.9b00940","article-title":"Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions","volume":"63","author":"Li","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib9","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/jm500823a","article-title":"Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors","volume":"57","author":"Bhat","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib10","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1021\/jm100342z","article-title":"ATPases as drug targets: insights from heat shock proteins 70 and 90","volume":"53","author":"Massey","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib11","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1021\/jo4002849","article-title":"Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90","volume":"78","author":"Kitson","year":"2013","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib12","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.0602650103","article-title":"A\u00a0biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues","volume":"103","author":"Gooljarsingh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112624_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.molcel.2011.04.023","article-title":"Client-loading conformation of the Hsp90 molecular chaperone revealed in the cryo-EM structure of the human Hsp90:Hop complex","volume":"42","author":"Southworth","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2020.112624_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2009.07.010","article-title":"Geldanamycin and its anti-cancer activities","volume":"290","author":"Fukuyo","year":"2010","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2020.112624_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ja.2010.161","article-title":"A\u00a0novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure\u2013activity relationships and anti-HCV activity in GS4.3 replicon cells","volume":"64","author":"Shan","year":"2011","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2020.112624_bib16","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/acs.jmedchem.9b00826","article-title":"Design and synthesis of fungal-selective resorcylate aminopyrazole Hsp90 inhibitors","volume":"63","author":"Huang","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1074-5521(03)00075-9","article-title":"Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90","volume":"10","author":"Jez","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112624_bib18","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1002\/chem.201905599","article-title":"Solution conformations explain the chameleonic behaviour of macrocyclic drugs","volume":"26","author":"Danelius","year":"2020","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2020.112624_bib19","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/acsinfecdis.9b00176","article-title":"Specific interactions between rifamycin antibiotics and water influencing ability to overcome natural cell barriers and the range of antibacterial potency","volume":"5","author":"Pyta","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112624_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nchembio.2203","article-title":"Structural and conformational determinants of macrocycle cell permeability","volume":"12","author":"Over","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112624_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejmech.2014.07.101","article-title":"Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors","volume":"85","author":"Li","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","article-title":"Crystal structure of an Hsp90\u2013geldanamycin complex: targeting of a protein chaperone by an antitumor agent","volume":"89","author":"Stebbins","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112624_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cbic.201402375","article-title":"New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90","volume":"16","author":"Hermane","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.112624_bib24","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1039\/c3cc43457e","article-title":"An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors \u2013 potential therapeutics in cancer and neurodegeneration","volume":"49","author":"Kitson","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112624_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nchem.1596","article-title":"Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90","volume":"5","author":"Kitson","year":"2013","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib26","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1039\/c2ob25744k","article-title":"Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90","volume":"10","author":"Wuest","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/jm049693a","article-title":"Synthesis and enzyme-specific activation of Carbohydrate\u2212Geldanamycin conjugates with potent anticancer activity","volume":"48","author":"Cheng","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1039\/B713407J","article-title":"Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites","volume":"6","author":"Lee","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib29","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1021\/jm900098v","article-title":"Potent cytotoxic C-11 modified geldanamycin analogues","volume":"52","author":"Tian","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib30","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1016\/j.bmcl.2005.08.013","article-title":"Structure-based design of 7-carbamate analogs of geldanamycin","volume":"15","author":"Rastelli","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112624_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/tx050237e","article-title":"Reaction of geldanamycin and C17-substituted analogues with Glutathione: product identifications and pharmacological implications","volume":"19","author":"Cysyk","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2020.112624_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cbic.201700616","article-title":"Heat shock proteins revisited: using a mutasynthetically generated reblastatin library to compare the inhibition of human and Leishmania Hsp90s","volume":"19","author":"Mohammadi-Ostad-Kalayeh","year":"2018","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.112624_bib33","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmcl.2008.01.072","article-title":"Conformational significance of EH21A1\u2013A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity","volume":"18","author":"Onodera","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112624_bib34","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1124\/dmd.108.022004","article-title":"Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin Hsp90 inhibitors: relevance for toxicity and mechanism of action","volume":"36","author":"Guo","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2020.112624_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3851\/IMP1631","article-title":"Synthesis and biological evaluation of heat-shock protein 90 inhibitors: geldanamycin derivatives with broad antiviral activities","volume":"20","author":"Li","year":"2010","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2020.112624_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2014.03.006","article-title":"Microarray-based screening of heat shock protein inhibitors","volume":"180","author":"Schax","year":"2014","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.ejmech.2020.112624_bib37","series-title":"Fortschritte Der Chemie Organischer Naturstoffe\/Progress in the Chemistry of Organic Natural Products","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-7091-3262-3_3","article-title":"Chemistry of the ansamycin antibiotics","author":"Rinehart","year":"1976"},{"key":"10.1016\/j.ejmech.2020.112624_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1107\/S2052520616003954","article-title":"The Cambridge structural database","volume":"72","author":"Groom","year":"2016","journal-title":"Acta Cryst B"},{"key":"10.1016\/j.ejmech.2020.112624_bib39","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1021\/jo00088a047","article-title":"Tandem [3,3]-Sigmatropic rearrangements in an ansamycin: stereospecific conversion of an (S)-Allylic alcohol to an (S)-Allylic amine derivative","volume":"59","author":"Schnur","year":"1994","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0092-8674(00)80314-1","article-title":"Identification and structural characterization of the ATP\/ADP-binding site in the Hsp90 molecular chaperone","volume":"90","author":"Prodromou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112624_bib41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jmb.2009.03.071","article-title":"Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design","volume":"388","author":"Immormino","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112624_bib42","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1096\/fj.11-188821","article-title":"Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90","volume":"25","author":"Millson","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.ejmech.2020.112624_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep17015","article-title":"First structural view of a peptide interacting with the nucleotide binding domain of heat shock protein 90","volume":"5","author":"Raman","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112624_bib44","unstructured":"Scigress Package FJ 2.6\/EU 3.1.9.\/2008-2019, (Fujitsu, Japan, n.d)."},{"key":"10.1016\/j.ejmech.2020.112624_bib45","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1021\/jm00019a011","article-title":"erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships","volume":"38","author":"Schnur","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib46","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/jm00019a010","article-title":"Inhibition of the oncogene product p185erbB-2 in\u00a0vitro and in\u00a0vivo by geldanamycin and dihydrogeldanamycin derivatives","volume":"38","author":"Schnur","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib47","unstructured":"R.P.D. Bank, RCSB PDB - 3Q5J: Crystal structure of the amino-terminal domain of HSP90 from Leishmania major, LMJF33.0312:M1-K213 in the presence of 17-DMAP-geldanamycin, (n.d.). https:\/\/www.rcsb.org\/structure\/3Q5J (accessed May 7, 2020)."},{"key":"10.1016\/j.ejmech.2020.112624_bib48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/acs.orglett.8b03792","article-title":"Isolation of 11,12-seco-Rifamycin W derivatives reveals a cleavage pattern of the rifamycin ansa chain","volume":"21","author":"Shi","year":"2019","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2020.112624_bib49","series-title":"Macrocycles in Drug Discovery","first-page":"37","article-title":"CHAPTER 2:recent advances in macrocyclic Hsp90 inhibitors","author":"Ramsey","year":"2014"},{"key":"10.1016\/j.ejmech.2020.112624_bib50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/pros.23239","article-title":"A\u00a0novel class of Hsp90 C-terminal modulators have pre-clinical efficacy in prostate tumor cells without induction of a heat shock response: C-terminal Hsp90 modulators with efficacy in prostate tumors","volume":"76","author":"Armstrong","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2020.112624_bib51","first-page":"786","article-title":"Could the anti-chaperone VER155008 replace temozolomide for glioma treatment","volume":"6","author":"Shervington","year":"2015","journal-title":"J.\u00a0Canc."},{"key":"10.1016\/j.ejmech.2020.112624_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2014.05.076","article-title":"SNX-25a, a novel Hsp90 inhibitor, inhibited human cancer growth more potently than 17-AAG","volume":"450","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2020.112624_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7164\/antibiotics.57.421","article-title":"Isolation and characterization of novel geldanamycin analogues","author":"Hu","year":"2004","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2020.112624_bib54","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cbic.200900246","article-title":"New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis","volume":"10","author":"Eichner","year":"2009","journal-title":"Chem. Eur. J. Chem. Bio."},{"key":"10.1016\/j.ejmech.2020.112624_bib56","unstructured":"ChemAxon https:\/\/chemaxon.com\/products\/calculators-and-predictors#logp_logd, (n.d)."},{"key":"10.1016\/j.ejmech.2020.112624_bib57","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1359-6446(05)03584-1","article-title":"Computing chemistry on the web","volume":"10","author":"Tetko","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112624_bib58","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/jm0603116","article-title":"Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90","volume":"49","author":"Ge","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib59","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1021\/jm8006068","article-title":"Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors \u2020","volume":"51","author":"Zhang","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm980403y","article-title":"Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin","volume":"42","author":"Roe","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112624_bib61","series-title":"Tools and Techniques in Biomolecular Science","author":"Divan","year":"2013"},{"key":"10.1016\/j.ejmech.2020.112624_bib62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/bip.10553","article-title":"Schiff base of gossypol with 3,6,9-trioxa-decylamine complexes with monovalent cations studied by mass spectrometry,1H-NMR, FTIR, and PM5 semiempirical methods","volume":"73","author":"Przybylski","year":"2004","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2020.112624_bib63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbamcr.2010.03.002","article-title":"Mutations that increase both Hsp90 ATPase activity in\u00a0vitro and Hsp90 drug resistance in\u00a0vivo","volume":"1803","author":"Zurawska","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420305961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420305961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:59:46Z","timestamp":1777528786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420305961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":62,"alternative-id":["S0223523420305961"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112624","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112624"}}